Abstract:A matrix-type transdermal drug delivery system of lornoxicam was prepared with the addition of combination of hydrophilic and hydrophobic polymers in different ratios. Transdermal patches of lornoxicam were designed with ethyl cellulose:polyvinylpyrrolidone and Eudragit RL 100:Eudragit RS 100 in different ratios with propylene glycol as plasticizer (5%) and tween 80 as permeation enhancer using the solvent evaporation technique. Evaluation of these formulations was performed through mechanical characterization and in vitro permeation studies. From the physicochemical and in vitro permeation data, the two formulations showing the best result (A3 and B3) were selected for further in vivo studies. The anti-inflammatory and analgesic effects of the patches were studied using the carrageenan paw edema model and hot plate test, respectively. The pharmacokinetic parameters were studied and recorded on animals. Formulations A3 and B3 exhibited greatest (311.04 μg and 306.32 μg, respectively) cumulative amount of drug release. The Higuchi model seemed to be the most appropriate model describing release kinetics from all patches (r(2) = 0.9847-0.9971). It was observed that both the patches significantly controlled inflammation and showed analgesic effect from the first hour (P < 0.05). Formulations A3 and B3 were found to enhance the bioavailability of lornoxicam by 3.1 and 2.7 times, respectively, with reference to the oral dosage form. Hence, lornoxicam can be formulated into transdermal patches to sustain its release characteristics and to avoid the disadvantages of oral routes. Formulations A3 and B3 were found to be the best choice to manufacture a lornoxicam transdermal drug delivery system.LAY ABSTRACT: The objective of the present work was to develop a matrix-type transdermal drug delivery system of lornoxicam with the addition of ethyl cellulose:polyvinylpyrrolidone and Eudragit RL 100:Eudragit RS 100 in different ratios with propylene glycol as plasticizer (5%) and tween 80 as permeation enhancer using the solvent evaporation technique. Lornoxicam is a non-steroidal anti-inflammatory drug that is used for the treatment of pain, inflammation, and arthritis. The prepared patches were evaluated for mechanical characterization and in vitro permeation studies. The formulations showing best results (A3 and B3) were selected further for in vivo and pharmacokinetic studies on animals. From the results, it was found that formulations A3 and B3 exhibited greatest cumulative amount of drug release, controlled inflammation, and showed analgesic effect from the first hour. Hence, lornoxicam can be formulated into transdermal patches, and formulations A3 and B3 were found to be the best choice to manufacture a lornoxicam transdermal drug delivery system.

Raman spectroscopy for the quantitative analysis of Lornoxicam in solid dosage forms

Vibrational and electronic investigations, thermodynamic parameters, HOMO and LUMO analysis on Lornoxicam by density functional theory

Quantitative analysis of solid dosage forms of Atenolol by Raman spectroscopy

Rapid Analysis of the In-Process Extract Solutions of Compound E Jiao Oral Liquid Using Near Infrared Spectroscopy and Partial Least-Squares Regression

Non-destructive testing of non-steroidal anti-inflammatory drugs using near-field infrared spectroscopy method

Quantitation of active pharmaceutical ingredient through the packaging using Raman handheld spectrophotometers: A comparison study

Spectrophotometric determination of celecoxib and tramadol in the new approved formulated dosage form using principle component regression assistive model

Rapid monitoring approaches for concentration process of lanqin oral solution by near-infrared spectroscopy and chemometric models

Development of Matrix-Type Transdermal Delivery of Lornoxicam: In Vitro Evaluation and Pharmacodynamic and Pharmacokinetic Studies in Albino Rats

Non-destructive Raman Method Development for Quantifying Active Pharmaceutical Ingredient in an Oral Suspension Through Plastic Dosing Syringes

Application of Near Infrared Spectroscopy Combined with Competitive Adaptive Reweighted Sampling Partial Least Squares for On-Line Monitoring of the Concentration Process of Wangbi Tablets

A Feasibility Study on the Non-Invasive Analysis of Bottled Compound E Jiao Oral Liquid Using Near Infrared Spectroscopy

Transdermal Delivery of Lornoxicam Hybrid Nanogel: Design, Preparation, Characterization, and In-Vitro Diffusion Evaluation

Development and validation of NIR-chemometric methods for chemical and pharmaceutical characterization of meloxicam tablets

Research Progress of Raman Spectroscopy and Raman Imaging in Pharmaceutical Analysis.

A Non-destructive Quantitative Transmission Raman Spectroscopy Method for Active Pharmaceutical Ingredient in Drug Product In-Use Samples Prepared in Dosing Vehicles

Rapid screening and multicomponent quantifications of active components of oral syrup over-the-counter medications by Raman and UV-visible spectroscopy and multivariate regression analysis

Transmission Raman Spectroscopic Quantification of Active Pharmaceutical Ingredient in Coated Tablets of Hot-Melt Extruded Amorphous Solid Dispersion

Real-Time Quantitative Evaluation of a Drug during Liposome Preparation Using a Probe-Type Raman Spectrometer

Biodegradable Polymers-Based Smart Nanocrystals for Loxoprofen Delivery with Enhanced Solubility: Design, Fabrication and Physical Characterizations

Non-Invasive Detection of Anti-Inflammatory Bioactivity and Key Chemical Indicators of the Commercial Lanqin Oral Solution by Near Infrared Spectroscopy